Brag House Holdings, Inc., to Create New Financial Powerhouse Anchored by Payments, Asset Management, and RWA Strategy with House of Doge - The Official Corporate Arm of the Dogecoin Foundation
Globenewswire· 2025-11-03 21:30
Combined entity poised to reshape digital payments, asset management, RWA tokenization, and digital media by applying Brag House's proven model to a global stage.NEW YORK and MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) ("Brag House") and its merger partner, House of Doge Inc. ("House of Doge"), the official corporate arm of the Dogecoin Foundation, today provided a strategic update on their definitive merger agreement. The merger is set to create a comprehensive financia ...
Adeia Announces Third Quarter 2025 Financial Results
Globenewswire· 2025-11-03 21:06
Signed 20 license agreements with new customers in key growth areas since separationPaid down $11 million of debt in the third quarter, bringing total debt repayment to $312 million since separationFiled patent infringement litigation against AMD SAN JOSE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) (the “Company” or “Adeia”) today announced financial results for the third quarter ended September 30, 2025. “Third quarter revenue of $87.3 million was in line with our expectations for ...
Adeia Initiates Patent Infringement Litigation Against AMD
Globenewswire· 2025-11-03 21:05
诉讼核心信息 - 公司已向美国德克萨斯州西区地方法院提起针对AMD的专利侵权诉讼 [1] - 诉讼涉及公司半导体知识产权组合中的10项专利 包括7项混合键合技术专利和3项先进工艺节点技术专利 [2] 公司立场与背景 - 公司采取法律行动旨在保护其知识产权及在基础半导体技术上的投资 并指出AMD产品广泛使用了其专利技术 [2] - 公司在提起诉讼前曾尝试通过非诉讼方式达成双方同意的解决方案但未果 [2] - 公司对诉讼结果持乐观态度 但仍对达成公平合理的安排持开放态度 [3] - 公司及其前身企业过去40年持续研发投入 拥有全球最大的知识产权组合之一 包含超过13000项全球专利资产 [3] 公司业务概览 - 公司是一家领先的研发与知识产权授权企业 专注于推动媒体和半导体行业的创新技术应用 [4] - 公司的基础创新是塑造未来数字娱乐和电子产品的技术解决方案的核心 [4] - 公司的知识产权组合为全球数百万用户日常使用的连接设备提供支持 [4]
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
Globenewswire· 2025-11-03 21:05
NEEDHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, being held on November 17-20, 2025 in London, United Kingdom. Presentation Details: Date: Tues ...
Zscaler Secures The Enterprise AI Lifecycle With Acquisition of Innovative AI Security Pioneer SPLX
Globenewswire· 2025-11-03 21:05
Acquisition extends Zscaler Zero Trust Exchange with shift-left AI asset discovery, automated red teaming and governance, advancing Zscaler’s AI security leadership Zscaler Acquires Innovative AI Security Pioneer SPLX Zscaler secures the enterprise AI lifecycle with acquisition of innovative AI security pioneer SPLX SAN JOSE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced it has acquired innovative AI security pioneer SPLX, extending th ...
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
Globenewswire· 2025-11-03 21:03
CORAL GABLES, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO, along with other members of Catalyst's management team, will participate in the Jefferies Global Healthcare Conference in London on Monday, November 17, ...
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
Globenewswire· 2025-11-03 21:00
RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs), announced today that its pioneering work was featured on Good Morning America (ABC News) in honor of World Blindness Awareness Month. The national feature highlighted the story of Lindsey Rambo, the second participant in Opus Genetics’ ongoing Phase 1/2 trial of gene therapy OPGx-LCA5, aimed a ...
GigaCloud Technology Inc Recognized in TIME’s ‘America’s Growth Leaders 2026’ List
Globenewswire· 2025-11-03 21:00
EL MONTE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced its inclusion in the TIME | America’s Growth Leaders 2026 list, a ranking honoring companies demonstrating exceptional growth, financial stability, and stock performance. Being named to the America’s Growth Leaders 2026 list places GigaCloud among the nation’s most accomplished business ...
Immutep Receives A$4.6 million R&D Tax Incentive from French Government
Globenewswire· 2025-11-03 21:00
Media Release SYDNEY, AUSTRALIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, is pleased to announce it has received a €2,588,954 (~ A$4,567,769 ) research and development (R&D) tax incentive payment in cash from the French Government under its Crédit d’Impôt Recherche scheme (CIR). The “Crédit d’Impôt Recherche” (CIR), meaning “Research Tax Credit”, is a French government ...
Aqua Metals and MOBY Robotics Sign MOU Establishing Collaboration Framework for Sustainable Refining of Deep-Sea Critical Minerals
Globenewswire· 2025-11-03 21:00
RENO, Nev., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable battery metals recycling and refining, today announced a Memorandum of Understanding (MOU) with MOBY Robotics Inc. to advance early leadership in sustainable refining of deep-sea polymetallic nodules. The collaborative framework intends to utilize Aqua Metals’ low-temperature AquaRefining™ process to refine nodules containing nickel, cobalt, manganese, and rare earths to advance domestic solutions for cr ...